Compounds > levonorgestrel
Page last updated: 2024-08-21

levonorgestrel and methotrexate

levonorgestrel has been researched along with methotrexate in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Campillo, NE; Guerra, A; Páez, JA1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Amant, F; Berteloot, P; De Greef, I; Deprest, J; Timmerman, D1
Cabar, FR; Pereira, PP; Zugaib, M1
Dueñas-Garcia, OF; Young, C1
Layman, K; Steele, BJ1

Reviews

1 review(s) available for levonorgestrel and methotrexate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

9 other study(ies) available for levonorgestrel and methotrexate

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Viable cervical pregnancy with levonorgestrel containing intrauterine device, treated successfully with methotrexate and mifepristone.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Jun-01, Volume: 120, Issue:2

    Topics: Abortifacient Agents; Cervix Uteri; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic

2005
Ectopic pregnancy following levonorgestrel emergency contraception.
    Contraception, 2009, Volume: 80, Issue:2

    Topics: Abortifacient Agents, Nonsteroidal; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Fallopian Tubes; Female; Humans; Levonorgestrel; Methotrexate; Pregnancy; Pregnancy, Ectopic; Treatment Failure

2009
Heterotopic cesarean scar pregnancy associated with a levonorgestrel-releasing intrauterine device.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 114, Issue:2

    Topics: Abortifacient Agents, Nonsteroidal; Adult; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leucovorin; Levonorgestrel; Methotrexate; Pregnancy; Pregnancy, Ectopic

2011
Ectopic Pregnancy After Plan B Emergency Contraceptive Use.
    The Journal of emergency medicine, 2016, Volume: 50, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Methotrexate; Pregnancy; Pregnancy, Ectopic; Young Adult

2016